The role of long non-coding RNAs in human carcinoma


  • Qiang Zhou Department of General Surgery, People’s Hospital of Chongqing Hi-Tech district, Chongqing, China
  • Minghua Deng Department of Hepatobiliary Surgery, Second affiliated Hospital of Chongqing Medical University, Chongqing, China
  • Jianping Gong Department of Hepatobiliary Surgery, Second affiliated Hospital of Chongqing Medical University, Chongqing, China



Long non-coding RNAs, Human carcinoma, HCC, Gene regulation


Long non-coding RNAs (LncRNAs) are usually longer than 200 nucleotides in length, which have 4 functions including signal, decoy, guide and scaffold in cells. Many studies have shown that the expression of LncRNAs is differentially between normal tissues and cancers, including hepatocellular carcinoma (HCC), bladder cancer, epithelial ovarian cancer, gastric cancer and other cancers, which suggests that alterations in the expression of LncRNAs could promote or inhibit tumor growth. However, the exact mechanisms by which LncRNAs play their roles in the normal and tumor cells remain unclear. This article reviews the role of LncRNAs in some common human carcinomas especially in HCC.


Ding B, Lou W, Xu L, Fan W. Non-coding RNA in drug resistance of hepatocellular carcinoma. Biosci Rep. 2018;38(5):BSR20180915.

Louro R, Smirnova AS, Verjovski-Almeida S. Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics. 2009;93(4):291-8.

Gao C, Sun J, Dong Y, Wang C, Xiao S, Mo L et al. Comparative transcriptome analysis uncovers regulatory roles of long non-coding RNAs involved in resistance to powdery mildew in melon. BMC Genomics. 2020;21(1):125.

Liu S, Zhao X, Zhang G, Li W, Liu F, Liu S et al. PredLnc-GFStack: A Global Sequence Feature Based on a Stacked Ensemble Learning Method for Predicting lncRNAs from Transcripts. Genes (Basel). 2019;10(9):672.

Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer lett. 2013;339(2):159-66.

Park JY, Lee JE, Park JB, Yoo H, Lee SH, Kim JH. Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development. Brain Tumor Res Treat. 2014;2(1):1-6.

Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes dev. 2009;23(13):1494-504.

Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10(38).

Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasi. Nature. 2010;464(7291):1071-6.

Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629-41.

Wei F, Yang L, Jiang D, Pan M, Tang G, Huang M et al. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis. Cancer Med. 2020;9(7): 2480-90.

Luo LH, Jin M, Wang LQ, Xu GJ, Lin ZY, Yu DD et al. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. J cellular physiol. 2020;235(9):6156-66.

Uthaya Kumar DB, Williams A. Long non-coding RNAs in immune regulation and their potential as therapeutic targets. Int Immunopharmacol. 2020;81(106279).

Tang Y, Ma N, Luo H, Chen S, Yu F. Downregulated long non-coding RNA LINC01093 in liver fibrosis promotes hepatocyte apoptosis via increasing ubiquitination of SIRT1. J Biochem. 2020;167(5):525-33

Mao G, Kang Y, Lin R, Hu S, Zhang Z, Hongyil L et al. Long Non-coding RNA HOTTIP Promotes CCL3 Expression and Induces Cartilage Degradation by Sponging miR-455-3p. Front Cell Dev Biol. 2019;7(161).

Zhou RM, Wang XQ, Yao J, Shen Y, Chen SN, Yang H et al. Identification and characterization of proliferative retinopathy-related long noncoding RNAs. Biochem Biophys Res Commun. 2015;465(3):324-30.

Yi Z, Li J, Gao K, Fu Y. Identifcation of differentially expressed long non-coding RNAs in CD4+ T cells response to latent tuberculosis infection. J Infect. 2014'69(6):558-68.

Gao L, Mai A, Li X, Lai Y, Zheng J et al. LncRNA-DQ786227-mediated cell malignant transformation induced by benzo(a)pyrene. Toxicol Lett. 2013;223(2):205-10.

Martens-Uzunova ES, Bottcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014;65(6):1140-51.

Zhu Y, Yu M, Li Z, Kong C, Bi J, et al. ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival. Urol. 2011;77(2):510:e1-5.

Zhang S, Du L, Wang L, Jiang X, Zhan Y, et al. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer. J Cell Mol Med. 2019;23(2):1396-405.

Song S, Wu Z, Wang C, Liu B, Ye X et al. RCCRT1 is correlated with prognosis and promotes cell migration and invasion in renal cell carcinoma. Urol. 2014;84(3):730e1-7.

Zhang Y, Pitchiaya S, Cieslik M, Niknafs YS, Tien JC, Hosono Y et al. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. Nat Genet. 2018;50(6):814-24.

Ren S, Liu Y, Xu W, Sun Y, Lu J, Wei M et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013;190(6):2278-87.

Wang GY, Zhu YY, Zhang YQ. The functional role of long non-coding RNA in digestive system carcinomas. Bull Cancer. 2014;101(9):E27-31.

Zhang E, He X, Zhang C, Su J, Lu X, Si X et al. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol. 2018;19(1):154.

Wang J, Su L, Chen X, Li P, Cai Q, Yu B et al. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother. 2014;68(5):557-64.

Zhuang M, Gao W, Xu J, Wang P, Shu Y. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun. 2014;448(3):315-22.

Wang Y, Liu X, Zhang H, Sun L, Zhou Y, Jin H et al. Hypoxia-inducible lncRNA-AK058003 promotes gastric cancer metastasis by targeting gamma-synuclein. Neoplasia. 2014;16(12):1094-106.

Xu Y, Li Y, Jin J, Han G, Sun C, Pizzi MP et al. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer. 2019;18(1):141.

Qiu J, Ye L, Ding J, Feng W, Zhang Y, Lv T et al. Effects of oestrogen on long noncoding RNA expression in oestrogen receptor alpha-positive ovarian cancer cells. J Steroid Biochem Mol Biol. 2014;141:60-70.

Liang H, Zhao X, Wang C, Sun J, Chen Y, Wang G et al. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer. Mol Cancer. 2018;17(1):96.

Wang C, Zou H, Chen A, Yang H, Yu X, et al. C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p. J Biochem. 2020;

Pan GF, Zhou XF, Zhao JP. Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism. Zhonghua Zhong Liu Za Zhi. 2017;39(2):102-8.

Biswas A, Shettar A, Mukherjee G, Kondaiah P, Desai KV. JMJD6 induces HOTAIR, an oncogenic lincRNA, by physically interacting with its proximal promoter. Biochem J. 2018;475(1):355-71.

Collina F, Aquino G, Brogna M, Cipolletta S, Buonfanti G, De Laurentiis M, et al. LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer. J Cancer. 2019;10(9):2018-24.

Zhu D, Xiao Z, Wang Z, Hu B, Duan C, Zhu Z et al. MEG3/MIR-376B-3P/HMGA2 axis is involved in pituitary tumor invasiveness. J Neurosurg. 2020;1-13.

Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012;48(1):1-8.

Ding Y, Wang X, Pan J, Ji M, Luo Z, Zhao P et al. Aberrant expression of long non-coding RNAs (lncRNAs) is involved in brain glioma development. Arch Med Sci. 2020;16(1):177-88.

Wu F, Tan GH, Ma CC, Li L. The non-coding RNA llme23 drives the malignant property of human melanoma cells. J Genet Genomics. 2013;40(4):179-88.

Hong CH, Ho JC, Lee CH. Steroid receptor RNA activator (SRA), a long noncoding RNA, activates p38, facilitates epithelial mesenchymal transformation, and experimental melanoma metastasis. J Invest Dermatol. 2020;140(7):1355-65.

Jiang Y, Jiang YY, Xie JJ, Mayakonda A, Hazawa M, et al. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nature communications. 2018;9(1):3619.

Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J et al. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am J Pathol. 2013;182(1):64-70.

Xie JJ, Jiang YY, Jiang Y, Li CQ, Lim MC, An O et al. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma. Gastroenterol. 2018;154(8):2137-51e1.

Shi H, Xu Y, Yi X, Fang D, Hou X. Current Research Progress on Long Noncoding RNAs Associated with Hepatocellular Carcinoma. Anal Cell Pathol (Amst). 2019;2019(1534607).

Lim LJ, Wong SYS, Huang F, Lim S, Chong SS, et al. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Res. 2019;79(20):5131-9.

Wang Y, He L, Du Y, Zhu P, Huang G, et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015;16(4):413-25.

Cao C, Sun J, Zhang D, Guo X, Xie L, et al. The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of beta-catenin in HCC cells. Gastroenterol. 2015;148(2):415-26e18.

Wang J, Cao C, Zeng Q, Dong Z. Long noncoding RNA UFC1 promotes metastasis and invasion of hepatocellular carcinoma cells in vitro via GSK-3beta/beta-catenin axis. Nan Fang Yi Ke Da Xue Xue Bao. 2019;39(6):679-84.

Yang L, Peng X, Li Y, Zhang X, Ma Y, Wu C et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019;18(1):78.

Hu M, Fu Q, Jing C, Zhang X, Qin T, Pan Y. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia. Biomed Pharmacother. 2020;125(109703).

Wu Y, Zhao Y M, Huan L, Zhao J, Zhou Y, Xu L et al. A LTR retrotransposon-derived long non-coding RNA lncMER52A promotes hepatocellular carcinoma progression by binding p120-catenin. Cancer Res. 2020;80(5).

Xu WH, Zhang JB, Dang Z, Li X, Zhou T, Liu J et al. Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma. Int J Biol Sci. 2014;10(7):664-76.

Huang M, Wang H, Hu X, Cao X. lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression. Oncoimmunol. 2019'8(1):e1518628.

Cui M, Zheng M, Sun B, Wang Y, Ye L, Zang X. A long noncoding RNA perturbs the circadian rhythm of hepatoma cells to facilitate hepatocarcinogenesis. Neoplasia. 2015;17(1):79-88.

Esfandi F, Salehnezhad T, Taheri M, Afsharpad M, Hafez AA, Oskooei VK et al. Expression assessment of a panel of long non-coding RNAs in gastric malignancy. Exp Mol Pathol. 2020;113(104383).

Liu Y, Feng J, Sun M, Yang G, Yuan H, Wang Y et al. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma. Cancer lett. 2019;454:158-70.

Xie H, Ma H, Zhou D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013;2013(136106).

Qin G, Tu X, Li H, Cao P, Chen X, et al. Long Noncoding RNA p53-Stabilizing and Activating RNA Promotes p53 Signaling by Inhibiting Heterogeneous Nuclear Ribonucleoprotein K deSUMOylation and Suppresses Hepatocellular Carcinoma. Hepatol. 2020;71(1):112-29.

Mo M, Liu S, Ma X, Tan C, Wei L, et al. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion. J Cancer Res Clin Oncol. 2019;145(8):2027-38.

Chen CY, Chen J, He L, Stiles B L. PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne). 2018;9(338).

Du J, Chen M, Liu J, Hu P, Guan H, Jiao X. LncRNA F11-AS1 suppresses liver hepatocellular carcinoma progression by competitively binding with miR-3146 to regulate PTEN expression. J Cell Biochem. 2019;120(10):18457-64.

Ma M, Xu H, Liu G, Wu J, Li C, Wang X et al. Metabolism-induced tumor activator 1 (MITA1), an Energy Stress-Inducible Long Noncoding RNA, Promotes Hepatocellular Carcinoma Metastasis. Hepatol. 2019;70(1):215-30.

Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer cell. 2014;25(5):666-81.

Dong J, Teng F, Guo W, Yang J, Ding G, Fu Z. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma. Cellular physiology and biochemistry. Int J exp cellular physiol, biochem pharmacol. 2018;51(5):2262-74.

Wang H, Liang L, Dong Q, Huan L, He J, Li B et al. Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-kappaB pathway in hepatocellular carcinoma. Theranostics. 2018;8(10):2814-29.

Yan S, Tang Z, Chen K, Liu Y, Yu G, et al. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. J Exp Clin Cancer Res. 2018;37(1):214.

Han XJ, Su HY, Shao HB, Xu K. Prognostic factors of spontaneously ruptured hepatocellular carcinoma. World J gastroenterol. 2015;21(24):7488-94.

Sheng N, Li Y, Qian R, Li Y. The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma. Biomed Pharmacother. 2018;98:577-84.

Li J, Gao J, Kan A, Hao T, Huang L. SNHG and UCA1 as prognostic molecular biomarkers in hepatocellular carcinoma: recent research and meta-analysis. Minerva Med. 2017;108(6):568-74.

Chen R, Cheng Q, Owusu-Ansah KG, Song G, Jiang D, et al. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-kappaB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma. Int J Biol Sci. 2020;16(3):495-503.

Wang Y, Jing W, Ma W, Liang C, Chai H, et al. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Cancer Biomark. 2018;22(2):227-36.






Review Articles